Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$56.12 +0.91 (+1.64%)
As of: Oct 22, 2026 · 10:48 AM EDT

Biomarin Pharmaceutical (BMRN) Debt Ratio (2012 - 2026)

Updated

Biomarin Pharmaceutical's Debt Ratio came in at 0.36 for Q2 2026.

Analysis

Biomarin Pharmaceutical (BMRN) Debt Ratio (2012 - 2026) Analysis & Trends

For FY2025, Biomarin Pharmaceutical's Debt Ratio was 0.08.

  • Going back by year, Debt Ratio was 0.07 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Debt Ratio in data going back to Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 0.39
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn 0.24
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 0.52
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn 0.42
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 0.08
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn 0.28
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn 0.60
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn 0.53
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn 0.31
10 Biomarin Pharmaceutical 10.84 Bn 4.70 Bn 786.91 Mn 0.36
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.36
Mar 31, 2026 0.17
Dec 31, 2025 0.08
Jun 30, 2024 0.07
Mar 31, 2024 0.07
Dec 31, 2023 0.07
Sep 30, 2023 0.07
Sep 30, 2020 0.06
Jun 30, 2020 0.07
Mar 31, 2020 0.08
Dec 31, 2019 0.08
Sep 30, 2018 0.08
Jun 30, 2018 0.08
Mar 31, 2018 0.08
Dec 31, 2017 0.08
Mar 31, 2017 0.01
Dec 31, 2016 0.01
Sep 30, 2016 0.01
Jun 30, 2016 0.01
Dec 31, 2012 0.01
API Access

Biomarin Pharmaceutical Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=BMRN&period=max&api_key=YOUR_API_KEY